Investing Profile
Pablo Lubroth(419)
Your Intro Paths to Pablo Lubroth
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Pablo Lubroth's investing connections
Connected to Ian Rountree (Cantos Ventures), Nabeel Hyatt (Spark Capital), Mar Hershenson (Pear VC), and 8 other investors on Signal.
Networks Pablo is a member of
University of Cambridge Network
103 CONNECTIONS
UCL Network
34 CONNECTIONS
UCL Network
34 CONNECTIONS
Johnson & Johnson Network
21 CONNECTIONS
Find Pablo Lubroth on
cbPablo Lubroth is on these Sector & Stage Rankings
Pharmaceuticals (Seed)BioTech (Series B)BioTech (Seed)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)New York CityLondonDigital Health (Series B)DeepTech (Series B)DeepTech (Series A)DeepTech (Seed)Pharmaceuticals (Pre-seed)DeepTech (Pre-seed)Digital Health (Pre-seed)BioTech (Pre-seed)Therapeutics (Series A)Therapeutics (Seed)Therapeutics (Series B)Therapeutics (Pre-seed)Digital Health (Series A)Digital Health (Seed)
Pablo Lubroth's Media (1)
Pablo Lubroth's Experience
Research UCLPresent
Corporate Development Horizon DiscoveryPresent
Investor Future Planet CapitalPresent
Co-Founder & Director Decoding BioPresent
EIR, VP Special Projects EnvedaPresent
Investor Hummingbird VenturesPresent
Investor & Board Observer EnvedaPresent
Venture Partner InterlagosPresent
VP Special Projects EnvedaPresent
Business Development BenevolentAIPresent
Research EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies - UCLPresent
General Partner InterlagosPresent
Co-Founder & Editor Decoding BioPresent
Investment Team Future Planet CapitalPresent
Investment Team Hummingbird VenturesPresent
Research University of CambridgePresent
Co-Founder Hera BiotechPresent
Co-Founder Decoding BioPresent
Investor and Board Observer EnvedaPresent
EIR and VP Special Projects EnvedaPresent
Corporate Development Associate Horizon DiscoveryPresent
Research Assistant | Molecular Neuroscience University of CambridgePresent
Research Assistant | Metabolic Pharmacology University College LondonPresent
Investor and Board Director NanoSyrinxPresent
Analyst | J&J Innovation Johnson & JohnsonPresent
Investment Manager UKI2S | Future Planet CapitalPresent
Investor EnvedaPresent
Investor and Board Observer Kaleidoscope.bioPresent
Investor and Board Observer Kernal Biologics, Inc.Present
Investor Waypoint BioPresent
Investor Ladder TherapeuticsPresent
Pablo Lubroth's Education
UCL MSc Biochemical Engineering
UCL BSc Pharmacology, Neuroscience
University of Cambridge MPhil Bioscience Enterprise
Founders who looked at Pablo Lubroth's profile also looked at these Scouts & Angels
